Not exact matches
His work indicates that this cell surface marker could
serve as a target for a novel brain cancer vaccine or T - cell therapies engineered to recognize and kill
tumors carrying that neoantigen.
«Nonetheless, the proof of concept studies we have obtained thus far are extremely encouraging, and we are confident that with proper support and efforts we could translate our findings into experimental therapeutics for a variety of solid
tumors that are driven by EphA2 overexpression, including breast, lung, prostate, pancreatic, and ovarian cancers,» said Pellecchia, who
serves as the founding director of the Center for Molecular and Translational Medicine at UCR.
Pre-clinical studies have shown that ALT - 803 activates the immune system to mobilize lymphocytes against
tumor cells and could potentially
serve as an important component in combination treatments.
The pathologist of the Department of Pathology at the University Hospital of Bellvitge August Vidal explained that «this tumorigenic transformation depends on Dicer protein that could
serve as a marker for the presence of
tumor cells, or
as a therapeutic target.»
«We used the algorithms to identify typical molecular signatures of stem cells [stemness signatures] that could help us understand
tumors and
serve as predictors of aggressiveness or clinical outcome.»
This analysis suggests that a rare subset of
tumor cells harbor different genetic alterations and that those cells
serve as the seeds for the recurrence of rhabdomyosarcoma.»
Lin28 may
serve as a biomarker for such treatment - resistant
tumors.»
This transformation recognizes that the immune inflammatory state
serves as a key mediator of the middle stages of
tumor development.
Hockfield came to MIT from Yale University, where she spent 20 years studying brain development and brain
tumors and
served as provost.
This scar tissue can
serve as a protective barrier for pancreatic cancers, allowing
tumors to resist chemotherapy and evade the body's own immune system.
«Protein
serves as natural boost for immune system's fight against infection,
tumors.»
«Thus, we have proven that Tie2 on pericytes
serves as a growth brake for vessels and, hence, also for
tumors,» said Laura Milde, who is one of the first authors of the publication.
Certain molecules on
tumors can
serve as targets for attack by cells of the immune system.
Therefore, it is useful to identify
tumor features that can
serve as «predictive biomarkers» to forecast how a person's
tumor might respond to a particular treatment.
One group of small, non-coding RNA molecules could
serve as a marker to improve cancer staging and may also be able to convert some advanced
tumors to more treatable stages, report a University of Chicago - based research team in the April 1, 2008, issue of the journal Genes & Development.
Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also
serves as the chair of the Department of Gynecologic Oncology, the executive director of the Center for Immunotherapy, and the co-Leader of the
Tumor Immunology and Immunotherapy research program.
The enzyme «isn't just a random by - product of a
tumor — it's something that can
serve as a marker for growth and malignancy,» says Ester Kwon, a former postdoctoral researcher in Bhatia's lab.
Dr. Ehrlich
serves as the Director of the Pediatric Trauma and is a member of the Solid
Tumor Oncology Program at CS Mott Children's Hospital at the University of Michigan.
That means the mice should be able to
serve as a new test bed for treatments aimed at shrinking children's
tumors.
Circulating cell - free DNA (cfDNA) isolated from plasma or serum by noninvasive procedures can
serve as a «liquid biopsy» and has potential
as a biomarker for the
tumor burden and survival prediction of breast cancer (BC).
A surgeon, educator and researcher, Kandel comes to UChicago Medicine from Columbia University College of Physicians and Surgeons in New York where she
served as the R. Peter Altman Professor of Surgery and Pediatrics in the Institute for Cancer Genetics and co-director of its Pediatric
Tumor Biology Laboratory.
More importantly, Tregs isolated from patients»
tumors were studded with higher - than - normal levels of the immune molecule CCR8, which
serves as a trigger for Tregs.
In all negative
tumors, occasional positive
tumor cells or coexisting reactive lymphocytes were present and
served as internal positive controls (arrows in C, right).
Their work encompasses several strategies, including: developing FL - HCC animal models to characterize
tumor - immune interactions, exploring if a mutated protein associated with FL - HCC could be targeted by immunotherapy, identifying immune checkpoints that could potentially
serve as targets for immunotherapy
as well
as biomarkers for analyzing patients, and evaluating the effectiveness of immunotherapy strategies against FL - HCC patient samples in the lab.
The lab also found that apoptotic
tumor cells
serve as potent instigators of the T cell immune response and has worked on developing cancer vaccines to mimic PND
tumor immunity.
Spheroids
serve as models for the development of healthy tissues and their maintenance in the living organism but also
as models for
tumor growth (Pampaloni et al. 2007).
Prior to his appointment
as cancer center director, Gilbertson
served as the founding director of the hospital's Molecular Clinical Trials Core and co-leader of the Neurobiology and Brain
Tumor Program.
This study design will establish whether (1) DAXX can
serve as a marker for early
tumor growth or later advanced / metastatic PCa, and (2) high DAXX expression associates with indolent versus lethal PCa.
Christina Curtis, PhD, MSc is an Assistant Professor in the Departments of Medicine (Oncology) and Genetics at Stanford University School of Medicine where she leads the Cancer Systems Biology Group and
serves as Co-Director of the Molecular
Tumor Board at the Stanford Cancer Institute.
Wistar researchers also create new tools for melanoma research, including three - dimensional «artificial skin» that
serves as a model for studying how living
tumors behave,
as well
as a proving ground for new therapeutics.
He
served as co-chair of the
Tumor Virology Program of the Abramson Cancer Institute.
Areas of focus include: understanding how tumour - reactive T cells and B cells promote patient survival in cancer; defining the effects of standard treatments on
tumor immunity; and using genomic approaches to identify novel tumour mutations that can
serve as target antigens for immunotherapy.
Therefore, we hypothesized that NSCs could
serve as an ideal cellular delivery platform for targeting antibodies to malignant
tumors.
Old, who also heads the Ludwig Institute for Cancer Research (LICR) New York Branch and has
served for many years
as director of LICR's worldwide scientific programs, says that, eventually, vaccines will treat a wide variety of cancer types, recruiting the immune system to stop the progression of patients»
tumors and helping to fully stabilizing the disease.
Polyphenols have been shown to reduce oxidative stress, may inhibit
tumor cell replication and can combat toxicity from certain pollutants, such
as dioxins, which
serve as endocrine disruptors.
Dogs are also helping advance the fight against human cancer
as they
serve as a model for various human
tumors.
The bacteria
serves as a delivery system to introduce the cancer marker to the patient's immune system and instruct it to eliminate the
tumor cells that express this marker.
These results suggest that
tumor antigen loaded CD40 - B may
serve as a practical alternative to DC in cell - based vaccine strategies for both dogs and humans with cancer.